Semaglutide vs Metformin
Written by Aaron CuhaReviewed Sep 2026
The short answer
The drug most people are given first and the drug most people ask about. They are not swappable. One is a cheap generic pill with decades of use and a steady record of finding nothing in ageing research. The other is a GLP-1 drug with large weight and heart trials. The overlap is type 2 diabetes. Everything else is different.
- Semaglutide people
- 42,363
- Semaglutide nulls
- 2
- Metformin people
- 489
- Metformin nulls
- 0
Dose
Approved titration: 0.25, 0.5, 1, 1.7 and 2.4 mg
0.25, 0.5, 1, 1.7 and 2.4 mg
The approved semaglutide ladder, in mg.
Dose
Approved medicine. No human dose established for unlabelled uses
Labeled amounts sit on the prescribing information. This page records what trials measured, not a personal dose.
FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity.
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
SemaglutideSemaglutide (GLP-1 receptor agonist)
A once a week shot for type 2 diabetes and weight loss. It is approved, and big studies show it also lowers the risk of heart attack and stroke.
Column B
MetforminMetformin hydrochloride (biguanide)
A cheap, very safe diabetes drug that many people take hoping to live longer. Big studies in people have not shown it helps with ageing. It also takes the edge off the muscle and fitness you gain from training.
Side by side, on the facts we can check
| What we compare | Semaglutide | Metformin |
|---|---|---|
| Category | Metabolic | Longevity |
| FDA status | FDA-approved (Ozempic and Rybelsus for type 2 diabetes; the Wegovy shot, the Wegovy pill approved Dec 2025, and Wegovy HD 7.2 mg approved Mar 2026 for weight management) | FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity. |
| Half-life | ~7 days | 4 to 9 hours (plasma), longer in erythrocytes |
| Molecular weight | 4,113.6 Da | 129.2 Da (165.6 Da as hydrochloride) |
| How it works | It switches on the GLP-1 receptor, a switch on cells that normally answers a gut hormone after you eat. That makes the body release insulin when blood sugar is high. It holds back glucagon, a hormone that raises blood sugar. It slows how fast the stomach empties. It also acts on the part of the brain that runs hunger, so people eat less. | It blocks part of the energy machinery in mitochondria, called complex I, and switches on AMPK, a fuel sensor. That makes the liver release less sugar and helps the body respond to insulin. The AMPK story is not the whole answer. Research groups still argue over how much comes from complex I, from another enzyme called mitochondrial glycerophosphate dehydrogenase, and from effects in the gut. |
| Studies in people | 15 | 7 |
| Evidence | Strong: 12 completed trials, 42,363 people given it | Moderate: 3 completed trials, 489 people given it |
| Legal status, US | FDA-approved, prescription only | Prescription only; approved for type 2 diabetes |
Frequently asked questions
What is the difference between Semaglutide and Metformin?
Semaglutide: A once a week shot for type 2 diabetes and weight loss. It is approved, and big studies show it also lowers the risk of heart attack and stroke. Metformin: A cheap, very safe diabetes drug that many people take hoping to live longer. Big studies in people have not shown it helps with ageing. It also takes the edge off the muscle and fitness you gain from training.
Which has stronger research evidence, Semaglutide or Metformin?
Each compound gets a band worked out from facts we counted, with the math shown. Semaglutide is Strong (12 completed trials, 42,363 people given it). Metformin is Moderate (3 completed trials, 489 people given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Semaglutide and Metformin FDA-approved?
Semaglutide: FDA-approved (Ozempic and Rybelsus for type 2 diabetes; the Wegovy shot, the Wegovy pill approved Dec 2025, and Wegovy HD 7.2 mg approved Mar 2026 for weight management). Metformin: FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity..
Related posts
Blog articles that cover Semaglutide or Metformin, newest first.
- Dispatch / Sep 27, 2026 / 8 minDispatch 001: Five Retatrutide Phase 3 Trials Have Finished And None Has Posted Results
- Metabolic / Sep 27, 2026 / 8 minTesofensine Is Not a Peptide: What It Is, the Trials, and the Heart-Rate Issue
- Longevity / Sep 27, 2026 / 12 minPeptides for Longevity: What the Evidence Actually Shows in 2026
- Metabolic / Sep 27, 2026 / 10 minOral GLP-1s in 2026: Wegovy Pill vs Foundayo (Orforglipron) vs Rybelsus, and What Is Coming
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.